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Incidence and Risk Factors of Ventricular Fibrillation Before Primary
Angioplasty in Patients With First ST-Elevation Myocardial Infarction:
A Nationwide Study in Denmark
Reza Jabbari, MD; Thomas Engstrøm, MD, PhD, DMSci; Charlotte Glinge, BM; Bjarke Risgaard, MD; Javad Jabbari, MSc, PhD;
Bo Gregers Winkel, MD, PhD; Christian Juhl Terkelsen, MD, PhD, DMSci; Hans-Henrik Tilsted, MD, PhD;
Lisette Okkels Jensen, MD, PhD, DMSci; Mikkel Hougaard, MD; Stephanie E. Chiuve, ScD; Frants Pedersen, MD, PhD;
Jesper Hastrup Svendsen, MD, DMSci; Stig Haunsø, MD, DMSci; Christine M. Albert, MD, MPH*; Jacob Tfelt-Hansen, MD, DMSci*
Background-—We aimed to investigate the incidence and risk factors for ventricular ﬁbrillation (VF) before primary percutaneous
coronary intervention (PPCI) amongpatientswithST-segment elevationmyocardial infarction (STEMI) in a prospective nationwide setting.
Methods and Results-—In this case-control study, patients presenting within the ﬁrst 12 hours of ﬁrst STEMI who survived to
undergo angiography and subsequent PPCI were enrolled. Over 2 years, 219 cases presenting with VF before PPCI and 441
controls without preceding VF were enrolled. Of the 219 case patients, 182 (83%) had STEMI with out-of-hospital cardiac arrest due
to VF, and 37 (17%) had cardiac arrest upon arrival to the emergency room. Medical history was collected by standardized
interviews and by linkage to national electronic health records. The incidence of VF before PPCI among STEMI patients was 11.6%.
Multivariable logistic regression analysis identiﬁed novel associations between atrial ﬁbrillation and alcohol consumption with VF.
Patients with a history of atrial ﬁbrillation had a 2.80-fold odds of experiencing VF before PPCI (95% CI 1.10 to 7.30). Compared
with nondrinkers, patients who consumed 1 to 7 units, 8 to 14 units, or >15 units of alcohol per week had an odds ratio (OR) of
1.30 (95% CI, 0.80 to 2.20), 2.30 (95% CI, 1.20 to 4.20), or 3.30 (95% CI, 1.80 to 5.90), respectively, for VF. Previously reported
associations for preinfarction angina (OR 0.46; 95% CI 0.32 to 0.67), age of <60 years (OR 1.75; 95% CI 1.20 to 2.60), anterior
infarction (OR 2.10; 95% CI 1.40 to 3.00), preprocedural thrombolysis in myocardial infarction ﬂow grade 0 (OR 1.65; 95% CI 1.14
to 2.40), and family history of sudden death (OR 1.60; 95% CI 1.10 to 2.40) were all associated with VF.
Conclusion-—Several easily assessed risk factors were associated with VF occurring out-of-hospital or on arrival at the emergency
room before PPCI in STEMI patients, thus providing potential avenues for investigation regarding improved identiﬁcation and
prevention of life-threatening ventricular arrhythmias. ( J Am Heart Assoc. 2015;4:e001399 doi: 10.1161/JAHA.114.001399)
Key Words: myocardial infarction • sudden death • ventricular ﬁbrillation
C oronary artery disease (CAD) and its ultimate conse-quence, myocardial infarction (MI), is believed to under-
lie 75% of deaths in patients with sudden cardiac death (SCD),
especially among men, and is the most common cause of
death in Western countries.1–4 It has been estimated that in
more than half of SCD cases, CAD is not recognized clinically
and SCD occurs as its ﬁrst symptom.2,5 In a sizable proportion
of these patients, ventricular ﬁbrillation (VF) is the primary
rhythm resulting in SCD.3 To date, clinically utilized risk
stratiﬁers for SCD, such as left ventricular ejection fraction,
are not speciﬁc for arrhythmic death and similarly predict
other modes of death from MI or CAD.5 Consequently, better
understanding of the factors that predispose patients with
CAD and/or MI to present with arrhythmic death or VF as the
ﬁrst manifestation are needed.
Toward this end, retrospective analyses of several clinical
trials and observational studies have sought to identify risk
factors that predict VF in the setting of acute MI6–10; however,
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the majority of VF events in these studies occurred during or
after revascularization and may represent a different patho-
physiologic process, as suggested by animal studies.11,12
Results from these studies may not be generalizable to the
majority of SCDs or VF arrests due to MI that occurs outside
the hospital.
Despite advances in delivery of primary percutaneous
coronary intervention (PPCI) for ST-segment elevation MI
(STEMI), an unknown proportion of patients with STEMI
experience VF prior to PPCI and thus may die before
revascularization. Three prospective case–control studies of
patients with STEMI and VF before PPCI identiﬁed associ-
ations between family history of sudden death, cumulative
ST elevation, left coronary artery culprit lesions, and absence
of preinfarction angina with VF.13–15 By design, these studies
included only VF survivors; therefore, the patients enrolled in
these studies may be less reﬂective of the general
population of STEMI patients with out-of-hospital cardiac
arrest due to VF. Moreover, in these studies, cases with
STEMI were matched to controls by age and sex; therefore,
the contribution of these factors to VF risk could not be
investigated,13–15 and no study has examined whether
alcohol intake might contribute to VF risk in the setting of
MI despite data suggesting important proarrhythmic proper-
ties.16–18
To address these gaps in our knowledge, the present study
aimed to investigate the incidence and risk factors for VF
before PPCI among survivors and nonsurvivors of STEMI in a
prospective nationwide setting.
Methods
Study Population
This study was designed as a nationwide prospective case–
control study among patients with ﬁrst STEMI between the
ages of 18 and 80 years recruited at all 4 percutaneous
coronary intervention (PCI) centers in Denmark. Patients
with out-of-hospital cardiac arrest were included on admis-
sion to PCI sites after resuscitation by trained emergency
medical service personnel. To avoid heterogeneity of under-
lying causes of VF, we limited our phenotype to include only
patients with ﬁrst STEMI, which also provided a discrete
population with similar pathology of underlying CAD for the
selection of both cases and controls. To qualify for the
study, all patients had to have cardiac symptoms lasting
≤12 hours and acute ST-segment elevation on ECG. All
cases and controls enrolled in the study underwent coronary
angiography and had either an acute coronary occlusion
documented at angiography or typical elevations of biomar-
kers. The majority underwent subsequent PPCI, and a few
underwent coronary artery bypass grafting. In patients with
diffuse or distal disease for which PCI was not technically
feasible, typical elevations of biomarkers were required to
ensure that the cause of ST elevation and arrest was acute
MI. Acute STEMI on ECG was deﬁned as (1) persistent ST-
segment elevation in 2 adjacent ECG leads of >0.1 mV in V4
through V6 or limb leads II, III, and aVF or (2) >0.2 mV in
lead V1 through V3 or (3) new left bundle branch block. The
culprit lesion was classiﬁed according to the judgment of the
PCI operator and, in the case of >1 lesion, the 1 that
corresponded with the location of ST elevation on the ECG
was chosen.
The case group was composed of patients who experi-
enced VF within the ﬁrst 12 hours of symptoms of STEMI
before PPCI, and the control group did not have VF during
this time period. VF before PPCI was deﬁned as VF
occurrence before guiding catheter insertion for PCI proce-
dure. Cases and controls who developed VF during PPCI
were both excluded because VF during PPCI is believed to
be reperfusion induced19–22; however, case patients with VF
before PPCI who continued to have VF during PPCI were
enrolled in the study. Other exclusions included VF after
PPCI, congenital heart defects, known structural heart
disease, use of class I and III antiarrhythmic drugs, recent
cancer, major surgery or trauma within 4 weeks, and
presentation with potassium concentration of <3 or
>5 mmol/L. Because we also planned to identify genetic
markers associated with VF, and because >90% of the
Danish populations are white Danes, we excluded nonwhite
Danes to reduce the risk of population stratiﬁcation for
future genetic analysis.
To avoid unintended loss of patients, particularly in the
case group, the study had permission from the National
Committee on Health Research Ethics to include patients
(both cases and controls) who were unconscious and who did
not have a family member available to provide informed
consent (protocol number: H-3-2010-133). Informed consent
for unconscious or dead patients was subsequently obtained
from the next of kin on arrival at the PCI center and
subsequently from patients who regained consciousness
when deemed competent to make decisions. Signed informed
consent is available for all patients enrolled in this study.
Procedures are in accordance with the ethical standards of
the national ethics committee on human research and with
the Helsinki Declaration of 1975, as revised in 1983.
Permission from the Danish Data Protection Agency was
also obtained before the study was initiated (Jr.nr. 2010-41-
5688).
Data Collection
All individuals with permanent residence in Denmark receive
a unique Civil Registration Number that enables linkage
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among nationwide registers at an individual level for various
sources and that is used for all healthcare-related services
from birth.
The Civil Registration Number was used to ascertain
hospitals records and discharge summaries from the
prehospital trauma and emergency doctors who, in most
cases, escort ambulances to the catheterization laboratory
and document the exact time of VF. Furthermore, the Civil
Registration Number was used to ascertain previous medical
history (eg, previous MI) for every patient from the national
electronic health records, which are linked to the national
patient registry. The national patient registry contains infor-
mation on all in- and outpatient activity in Danish hospitals
and emergency departments since 1978. Diagnoses are
coded according to the International Classiﬁcation of Dis-
eases (ICD), with ICD-8 codes used from 1977 to 1993 and
ICD-10 codes used since 1994.23
Baseline Demographics, Medical History, and
Lifestyle Information
Previous medical history was also collected by research
coordinators at the study sites using a predesigned stan-
dardized questionnaire including all baseline characteristics
such as family history of sudden death that was similarly
administered to cases and controls. All questions in this
questionnaire (Tables 1 and 2) were considered predeﬁned
research questions. The interview was carried out in a similar
fashion for cases and controls by trained study personnel. If
the patient was unable to provide us with information, the
next of kin was contacted. The questionnaire collected
information on baseline demographics (Table 1), education,
prior medical history, smoking status, alcohol intake, and
previous medications. For alcohol intake, we asked the
patients, “How many units of alcohol do you drink each
week?” One unit of alcohol was deﬁned as a beer, a single
measure of spirits, or a glass of wine (12 g=1 unit). We also
collected information on family history of sudden death, MI,
and stroke (as reported by the patients, their families, or as
determined from their previous medical records). Family
history of sudden death in ﬁrst-degree relatives (biological
parents, brothers, sisters) was deﬁned as sudden, natural,
unexpected death from an unknown or cardiac cause in
parents or siblings aged <80 years. In witnessed cases, the
family member died within 1 hour of an acute change in
cardiovascular status. For unwitnessed cases, the person was
last seen alive and functioning normally within 24 hours of
being found dead.24 Additional detailed information regarding
cardiac symptoms (angina, dyspnea, palpitations, presyncope,
and syncope) experienced within the last 12 months and
contact with the healthcare system on the basis of these
symptoms was also collected (Table 2). Presenting clinical
characteristics at the time of STEMI were collected from
medical records (Table 3).
ECG Measurements
ECGs were taken at the moment of hospital admission for the
index STEMI. ST deviation, PQ, QRS, and QTc were calculated.
QTc was calculated using Bazett’s formula, and ECGs with left
and right bundle branch blocks were excluded (n=77) from
the QTc measurements. For ST-segment deviation analysis,
ECGs with left bundle branch block were excluded (n=30).
STEMI Registry
To evaluate the representativeness of our case–control
population for all STEMI patients presenting at the 4 PCI
centers in Denmark, we performed the following screening
procedures.
To evaluate the representativeness of our case population
and to estimate the incidence of VF before PPCI, we screened
all STEMI patients admitted to 1 of the 4 centers, Rigshos-
pitalet, where information on VF has been collected system-
atically on consecutive patients admitted for STEMI in a local
hospital registry (WEB-PATS registry) since October 1999
(Figure 1). Rigshospitalet is the PPCI center for all of eastern
Denmark, with a catchment area of 2.5 million inhabitants,
corresponding to 45% of the entire Danish population.
To evaluate the representativeness of the control popula-
tion, we also screened all STEMI patients admitted to 2 of the
4 PPCI centers (Rigshospitalet and Aalborg University Hospi-
tal) during the 8-month inclusion period of the control
participants. These 2 centers serve all of eastern and
northern Denmark, with a catchment area of 3.1 million
persons, corresponding to 56% of the entire Danish popula-
tion (Figure 2).
Statistical Methods
Medians or proportions of baseline and presenting character-
istics were computed for cases and controls, and signiﬁcance
of associations was tested using the Wilcoxon rank-sum test
for continuous variables and the v2 test or Fisher exact test (as
appropriate) for categorical variables. A 2-tailed P value ≤0.05
was considered statistically signiﬁcant. A logistic regression
model was constructed to identify clinical risk factors that
preceded STEMI and were associated with subsequent VF
(Tables 1 and 2). Because the majority of presenting charac-
teristics (Table 3) such as creatine kinase-MB level, left
ventricular ejection fraction, 12-lead ECG, time from onset of
symptoms to PPCI, postprocedural thrombolysis in myocardial
infarction ﬂow, and Killip class were recorded after STEMI with
VF and could have been inﬂuenced by the VF arrest, we chose
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Table 1. Baseline Characteristics
Variables Cases (n=219) Controls (n=441) P Value
Female sex, n (%) 30 (14) 102 (23) 0.004
Median age at index infarction, years (IQR) 59 (53 to 68) 61 (52 to 66) 0.020
Cardiovascular risk profile
Body mass index, kg/m2 (IQR) 27.5 (25 to 29) 26.7 (24 to 29) 0.300
Smoking, pack-year (IQR) 25 (11 to 41) 23 (5 to 40) 0.200
Smoking, n (%)
Never 35 (16) 91 (21)
0.300Past 66 (30) 116 (26)
Current 116 (54) 233 (53)
Alcohol per week, unit* (IQR) 7 (1 to 15) 3 (1 to 9) <0.001
Alcohol units per week (categorized), n (%)
Nondrinkers 36 (17) 117 (27)
<0.001
Normal (1 to 7) 81 (38) 202 (46)
Moderate high (8 to 14) 37 (18) 62 (14)
High (>15) 58 (27) 58 (13)
Diabetes, n (%) 23 (10) 38 (8) 0.400
Hypertension, n (%) 93 (42) 153 (35) 0.052
COPD, n (%) 10 (5) 25 (6) 0.600
Hypercholesterolemia, n (%) 88 (40) 143 (32) 0.049
Stroke, n (%) 16 (7) 23 (5) 0.300
Atrial fibrillation, n (%) 14 (7) 10 (3) 0.020
Depression, n (%) 23 (11) 53 (12) 0.600
Epilepsy, n (%) 4 (2) 5 (1) 0.500
Family history, n (%)
Sudden death 81 (38%) 112 (26%) 0.001
MI 82 (41%) 162 (38%) 0.500
Stroke 31 (16%) 57 (14%) 0.500
Medication before MI, n (%)
b-blockers 17 (8) 39 (9) 0.700
Statins 49 (23) 55 (12) 0.001
ACE/ARB blockers 40 (19) 75 (17) 0.500
Aspirin 21 (10) 35 (8) 0.400
Location of cardiac arrest, n (%)
Out-of-hospital cardiac arrest 182 (83) —
On arrival at the ER before PPCI 37 (17) —
Coma at arrival to PCI center 82 (37%) —
ST elevation on ECG after cardiac arrest 139 —
In-hospital death 38 (17) 3 (1) <0.001
Education after primary school n (%) Cases (n=205) Controls (n=438)
None 28 (14) 80 (18)
0.400
High school 15 (7) 30 (7)
Trade school 95 (46) 192 (44)
University (≤3 years) 39 (19) 93 (22)
University (>3 years) 28 (14) 43 (9)
ST elevation on ECG after cardiac arrest is deﬁned as patients with out-of-hospital cardiac arrest due to ventricular ﬁbrillation who developed ST-segment elevation MI on ECG after the
arrest. ACE indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; COPD, chronic obstructive pulmonary disease; ER, emergency room;
MI, myocardial infarction; PCI, percutaneous coronary intervention; PPCI, primary percutaneous coronary intervention.
*1 unit of alcohol=12 g (1 drink).
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not to include these variables in the logistic regression model.
We assumed that infarct location and preprocedural throm-
bolysis in myocardial infarction ﬂow would not be inﬂuenced
by VF and/or prolonged hypoxia; therefore, these variables
were considered in the model building. Because infarct
location and culprit vessel are highly correlated, we chose to
include only infarct location in the logistic regression model.
Missing data for the baseline characteristics and variables
measured in advance of STEMI with VF were <2% except for
educational level (3%), healthcare contact prior to STEMI (4%),
and syncope or presyncope (15%). A variable with missing data
>4% (syncope or presyncope) was not included in the logistic
regression model. For the remaining variables, only patients
with complete information were used in univariable and
multivariable analyses. Age as a continuous variable was fairly
normally distributed but was categorized for easier interpre-
tation. Alcohol intake and smoking in pack-years was not
normally distributed (right skewed), even after log transfor-
mation, and thus both variables were categorized. Regarding
outliers, if the patients reported high units of alcohol intake per
week or smoking in pack-years, we contacted the patients or
relatives to verify the reported values, and these veriﬁed
outliers are included in the analysis for all patients.
An initial multivariable model was built by including any
covariate with P<0.20 on the univariate test. Because age,
sex, family history of sudden death, smoking, and preinfarc-
tion angina were previously associated with VF,6–8,13 these
variables were included regardless of univariate P value. After
building the initial model, we sequentially added covariates
that did not meet P<0.20 on univariate testing. A covariate
was retained if it was signiﬁcant or changed the coefﬁcient of
a risk factor by >10% and was excluded if it changed the
standard error by >10%. Adjusted odds ratios (ORs) and
accompanying 95% conﬁdence intervals (CIs) were computed
to determine the effect of each variable on the risk of VF. The
Hosmer-Lemeshow goodness-of-ﬁt test (by forming 10
groups) was used to evaluate the ﬁnal model, and area under
the receiver operating characteristic curve for the logistic
regression model was used to measure prediction accuracy.
Tests for linear trend across alcohol intake categories were
performed by assigning the median value to each category
and modeling this as a continuous variable in separate logistic
regression models. To test for a curvilinear association, a
quadratic term (average intake squared) was added to the
linear term in a separate model. We also examined the
possibility of a nonlinear relationship between alcohol and VF
risk nonparametrically using restricted cubic spline transfor-
mations with 4 knots (Figure 3). All analyses were performed
using the Stata software package version 12.0 (StataCorp).
Results
Consecutive STEMI Registries
At the largest center, 1901 consecutive patients with acute
STEMI due to symptoms and/or ECG changes were admitted
to Rigshospitalet during the 2-year enrollment period
(Figure 1). VF occurred before PCI in 221 patients (11.6%)
(Figure 1). This number represents all STEMI patients who
underwent angiography and subsequent PPCI including
patients of nonwhite ethnicity and those with prior CAD or
MI. Of these 221 VF patients, 43 (19%) were excluded based
on exclusion criteria, 20 (9%) who potentially could have been
enrolled in the study were missed, and 158 (72%) were
included in the study. Compared with the VF cases included in
the study, the missed-case group did not differ with respect to
age (P=0.400) or sex (P=0.500).
During the 8-month period during which controls were
enrolled in the study, 664 STEMI patients with symptom
duration ≤12 hours were treated with PPCI at 2 of the 4
centers (Figure 2). Of these patients, 126 (19%) were not
enrolled in the study because of admission during weekends
or holidays or expedited discharge to local hospitals. The
majority (283 patients, 43%) were excluded based on the
exclusion criteria, and 255 (38%) were included. Compared
with the controls included in the study, the missed-control
group (19%) did not differ with respect to age (P=0.400) or sex
(P=0.900).
Table 2. Symptoms Prior to STEMI and Ventricular Fibrillation
Cardiac Symptoms Within 1 Year Prior to STEMI, n (%) Cases (n=219) Controls (n=441) P Value
Angina 105 (49) 284 (64) <0.001
Dyspnea 52 (25) 123 (28) 0.400
Palpitations 15 (7) 41 (9) 0.400
Syncope* 3 (2) 4 (1) 0.400
Presyncope* 2 (1) 14 (4) 0.200
Healthcare contact within 1 year prior to STEMI due to cardiac symptoms 37 (18) 61 (14) 0.200
STEMI indicates ST-segment elevation myocardial infarction.
*Missing value for syncope or presyncope (15%).
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Case–Control Series
In the case–control series performed at all 4 PCI centers, 219
case patients with VF and 441 control patients without VF in
the setting of STEMI were included. The baseline character-
istics are shown in Table 1. In the case group, 82 (37%)
patients who underwent angiography were unconscious at
arrival at the hospital, and the informed consent was signed
Table 3. Presenting Characteristics
Variables Cases (n=219) Controls (n=441) P Value
Time from symptom to PPCI, min (IQR) 145 (107 to 207) 187 (127 to 296) <0.001
LVEF after PCI, meanSD (%)* 41.6511.9% 46.210.45% <0.001
CK-MB max, lg/L (IQR) 232 (76 to 393) 138 (51 to 277) <0.001
Time to peak, min (IQR) 783 (552 to 967) 660 (497 to 880) <0.001
Acute CABG, n (%) 18 (9) 13 (3) 0.002
Culprit lesion, n (%)
LAD 118 (54) 202 (46)
0.001
RCA 71 (33) 185 (42)
CX 23 (11) 54 (12)
>1 5 (2) 0 (0)
Infarct location, n (%)
Anterior 123 (57) 202 (46)
0.009
Nonanterior 94 (43) 239 (54)
Preprocedural TIMI flows, n (%)
TIMI 0 126 (58) 221 (50)
0.080
TIMI I 17 (8) 45 (10)
TIMI II 19 (9) 65 (15)
TIMI III 56 (25) 108 (25)
Postprocedural TIMI flows, n (%)
TIMI 0 8 (4) 8 (2)
0.140
TIMI I 0 (0) 0 (0)
TIMI II 9 (4) 10 (2)
TIMI III 201 (92) 421 (96)
ECG† Cases (n=209) Controls (n=401)
PQ interval, milliseconds (IQR) 164 (146 to 192) 164 (148 to 182) 0.300
QRS interval, milliseconds (IQR) 96 (88 to 108) 97 (88 to 106) 0.700
QTc interval, milliseconds (IQR) 415 (404 to 440) 416 (406 to 432) 0.700
LBBB, n (%) 21 (10) 9 (2) <0.001
RBBB, n (%) 30 (14) 17 (4) <0.001
ST deviation, mm (IQR) 4 (2 to 6) 2 (1 to 4) <0.001
Killip class, n (%)† Cases (n=171) Controls (n=355)
I 145 (85) 343 (97)
<0.001
II 9 (5) 12 (3)
III 7 (4) 0 (0)
IV 10 (6) 0 (0)
CABG indicates coronary artery bypass grafting; CK-MB, creatine kinase-MB; CX, circumﬂex artery; LAD, left anterior descending; LBBB, left bundle branch block;
LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; PPCI, primary percutaneous coronary intervention; RBBB, right bundle branch block;
RCA, right coronary artery; TIMI, thrombolysis in myocardial infarction.
*LVEF cases, n=184; LVEF controls, n=429.
†Missing value for Killip class (20%), for ECG (8%) and for LVEF (7%).
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by the next kin. VF occurred out-of-hospital in 83% of the
cases, and the remainder (17%) occurred on arrival at the
hospital (Table 1). Eighty VF patients had STEMI on ECG and
developed VF afterward. In the rest of the cases (n=139), the
STEMI ECG was recorded after the VF arrest. In-hospital death
occurred in 17% (n=38) of the cases and 1% (n=3) of the
controls (P<0.001).
Compared with the control group, patients in the case
group were more likely to be younger, male, have a history of
atrial ﬁbrillation (AF) or hypercholesterolemia, and a family
history of sudden death. Furthermore, the proportion on statin
therapy was higher in the case group compared with the
control group, likely due to the higher degree of hypercho-
lesterolemia in the case group (Table 1). Median levels of
average weekly alcohol intake were higher in the case group
(7 units per week) as compared with the control group
(3 units per week) without VF (P=0.001). A history of angina
prior to STEMI was more likely in the control group compared
with the case group, but no difference was observed in self-
reported contact with the healthcare system due to cardiac
symptoms within a year prior to STEMI (Table 2).
The angiographic and other presenting characteristics at
the time of STEMI according to case and control status are
outlined in Table 3. Patients with VF had shorter times from
symptom onset to PPCI, lower left ventricular ejection
fraction, larger infarct size (based on maximal creatine
kinase-MB peak), and higher Killip class and were more likely
to have anterior infarctions with left anterior descending
artery occlusions. Regarding the index ECG at the time of
STEMI, the case group was more likely to have left or right
bundle branch block and higher baseline ST-segment devia-
tion (Table 3).
The results of univariate and multivariate logistic regres-
sion analysis are summarized in Table 4. Patients who were
aged <60 years had 1.75-fold elevated odds of experiencing
VF with STEMI compared with those aged ≥60 years. When
analyzed as a continuous variable, the OR for each 10 years
of age was 0.73 (95% CI 0.59 to 0.88). Prior history of AF,
Figure 1. Flow diagram demonstrating screening of STEMI patients for VF at 1 center
(June 1, 2011 to May 31, 2013): All STEMI patients presenting to the largest center
(Rigshospitalet) were screened to estimate the incidence of VF prior to PPCI in STEMI and
to evaluate the representativeness of our case population to all STEMI patients presenting
to percutaneous coronary intervention centers. PPCI indicates primary percutaneous
coronary intervention; STEMI, ST-segment elevation myocardial infarction; VF, ventricular
ﬁbrillation.
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family history of sudden death, use of statins, and alcohol
intake >7 units per week (up to 1 drink per day) were
positively associated with VF after multivariable adjustment
(Table 4). For alcohol intake, the test for linear trend across
categories was signiﬁcant (P<0.001), and patients who
reported drinking >15 units of alcohol per week were at the
highest odds of developing VF (OR 3.30; 95% CI 1.80 to 5.90)
compared with nondrinkers.
Preinfarction angina was inversely associated with VF (OR
0.46; 95% CI 0.32 to 0.67) after multivariable adjustment. The
included presenting characteristics of anterior infarct and
preprocedural thrombolysis in myocardial infarction ﬂow
grade 0 were also associated with VF. Other standard
cardiovascular risk factors including hypertension, hypercho-
lesterolemia, and smoking (categorically and continuously)
were not signiﬁcantly associated with VF after multivariable
adjustment. Although highly signiﬁcant in the univariate
analysis, male sex was no longer signiﬁcant in the multivariate
model after controlling for alcohol intake (P=0.06). The area
under the receiver operating characteristic curve for the ﬁnal
logistic regression model was 0.730 and the Hosmer-Leme-
show goodness-of-ﬁt test was P=0.370, indicating acceptable
risk accuracy and model, respectively.
We further examined the relationship between alcohol
intake and VF in separate multivariable models controlling for
the above covariates by adding a quadratic term to the linear
term for alcohol intake. These models suggested a possible
curvilinear component (Pquadratic=0.048). We further tested for
departure from linearity using the raw continuous value for
alcohol intake in a restricted cubic spline model (Figure 3). In
Figure 3. Restricted cubic spline for alcohol consumption. Mul-
tivariate odds ratio of ventricular ﬁbrillation before percutaneous
coronary intervention as a function of alcohol intake in units per
week. Data are ﬁtted by a restricted cubic spline logistic regression
model and controlled for age, sex, preinfarction angina, infarct
location, preprocedural thrombolysis in myocardial infarction ﬂow,
atrial ﬁbrillation, family history of sudden death, statins before ST-
segment elevation myocardial infarction, hypercholesterolemia,
hypertension, and smoking. The 95% CIs are indicated by dashed
lines.
Figure 2. Representativeness of the control population to all STEMI
patients at 2 centers: Flow diagram demonstrating screening and
inclusion of STEMI at 2 of the 4 centers during the 8-month enrollment
of the controls. STEMI indicates ST-segment elevation myocardial
infarction.
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this model, there was a nonlinear relationship between
alcohol intake and VF (Pnonlinear trend=0.0003). The shape of
the curve is consistent with an increased VF risk at >7 units
per week with leveling off of the curve at intakes of alcohol
>14 units per week (Figure 3).
Discussion
In this nationwide study of patients with ﬁrst STEMI who
survived to undergo angiography, we identiﬁed several patient
characteristics associated with signiﬁcantly higher odds of
experiencing VF before PPCI after controlling for cardiovas-
cular risk factors, infarct location, and thrombolysis in
myocardial infarction ﬂow. These independent risk factors
include age of <60 years, family history of sudden death,
absence of preinfarction angina, use of statins, history of AF,
and alcohol intake >7 units per week. Traditional CAD risk
factors such as smoking, diabetes, hypertension, and hyper-
cholesterolemia did not predict risk. These data, along with
those from prior studies,13–15 suggest that certain patients
may be particularly vulnerable to the proarrhythmic effects of
ischemia and more likely to present with VF or SCD as their
manifestation of CAD. In our series of patients, 11.6% of
patients with STEMI transferred for PPCI experience VF prior
to undergoing the procedure. Consequently, primary preven-
tion of VF in STEMI patients is of the utmost importance, and
our study suggests that several factors may help identify high-
risk patients and, in the case of alcohol, could potentially be
modiﬁed to lower risk.
To our knowledge, our study is the ﬁrst to examine the
relationship between alcohol consumption and risk of VF in
the setting of STEMI. Higher intake of alcohol has been
linearly associated with lower risks of MI,25 whereas the
relationship with SCD is U-shaped, with lower risks observed
only at low to moderate levels of alcohol consumption (2 to
6 drinks per week)16,17 and higher risks observed with heavy
consumption (>6 drinks per day).18 These divergent relation-
ships could be explained if the favorable effects of alcohol on
atherosclerosis and thrombosis are offset by potential
proarrhythmic effects at higher levels of intake. Our study
supports this hypothesis and suggests that the proarrhythmic
properties of alcohol may be observed even at fairly moderate
levels of intake. Because both cases and controls in our study
had STEMI, we were able to examine the relationship of
Table 4. Univariate and Multivariate Analysis of Risk Factors of Ventricular Fibrillation
Variable Contrast
Univariate Multivariate†
OR 95% CI P Value OR 95% CI P Value
Younger age Aged <60 years vs ≥60 years 1.38 0.99 to 1.90 0.050 1.75 1.20 to 2.60 0.005
Male sex Male vs female 1.90 1.21 to 2.95 0.005 1.65 0.98 to 2.75 0.060
Alcohol
1 to 7 units/week Nondrinkers 1.30 0.83 to 2.05 0.300 1.30 0.80 to 2.20 0.300
8 to 14 units/week Nondrinkers 1.94 1.12 to 3.37 0.020 2.30 1.20 to 4.20 0.008
≥15 units/week Nondrinkers 3.25 1.93 to 5.50 <0.001 3.30 1.80 to 5.90 <0.001
Atrial fibrillation Yes vs no 2.94 1.29 to 6.73 0.010 2.80 1.10 to 7.30 0.040
Preinfarction angina Yes vs no 0.53 0.38 to 0.73 <0.001 0.46 0.32 to 0.67 <0.001
FH of sudden death Yes vs no 1.80 1.27 to 2.56 0.001 1.60 1.10 to 2.40 0.010
Infarct location Anterior vs nonanterior 1.55 1.10 to 2.10 0.009 2.10 1.40 to 3.00 <0.001
TIMI flow before PPCI TIMI flow grade 0 vs grade 1 to 3 1.35 0.97 to 1.90 0.070 1.65 1.14 to 2.40 0.008
Statins before STEMI Yes vs no 2.05 1.34 to 3.15 0.001 2.10 1.15 to 4.0 0.020
Hypercholesterolemia Yes vs no 1.40 1.00 to 1.95 0.050 0.90 0.55 to 1.50 0.800
Hypertension Yes vs no 1.39 0.99 to 1.94 0.050 1.20 0.79 to 1.85 0.400
Smoking
Past Past vs never 1.48 0.90 to 2.40 0.100 1.18 0.68 to 2.00 0.600
Current Current vs never 1.30 0.83 to 2.00 0.300 1.10 0.66 to 1.85 0.700
Study site 1.00 0.87 to 1.12 0.900 1.00 0.87 to 1.15 1.000
FH indicates family history; OR, odds ratio; PPCI, primary percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; TIMI, thrombolysis in myocardial
infarction.
219 cases and 441 controls were included from the 4 centers.
†200 cases and 431 controls from the 4 centers included in the full multivariable model. Because the ratio of cases to controls did differ at each of the sites, we added a variable study site
to the multivariable model to control for any unmeasured differences between cases and controls enrolled at each of the 4 centers.
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alcohol to VF independent of its association with MI. Patients
who reported drinking 8 to 14 units of alcohol per week had
2.3-fold signiﬁcantly higher odds of VF in the setting of STEMI.
This risk continued to increase but to a lesser degree at
higher levels of intake, with patients consuming >15 drinks
being at a 3.3-fold increased VF risk.
Moderate levels of alcohol intake have also been linked to
incident AF,26,27 and a prior history of AF was found to be a
risk factor for VF (OR 2.8) before PPCI in this population of
STEMI patients, even after controlling for alcohol intake. Our
study adds to the growing literature regarding the link
between AF and ventricular arrhythmias and SCD. Population-
based studies have previously associated history of AF with
SCD,28 and patients with AF appear to derive a greater beneﬁt
from primary prevention implantable cardioverter-deﬁbrilla-
tors.29–31 Recently, a large population-based case–control
study found similar elevations in the risk of VF arrest
associated with a preceding diagnosis of AF.32 AF at initial
presentation in the setting of acute MI has also been
associated with increased risk of in-hospital VF33 and total
mortality.34 Our results suggest that AF patients may have a
lower threshold for VF in the setting of MI, and this could
account for the increased risk of SCD in population-based
studies. Heritable factors and cardiac channelopathies have
been identiﬁed for VF and AF35; therefore, further research
regarding joint pathways affecting cardiac electrical function
in the atrium and ventricle is needed to further our
understanding regarding the link between AF and VF.
Our study also supports prior work showing that a genetic
predisposition for VF and/or SCD exists in the setting of
MI.13,36 These studies showed that a family history of sudden
death among parents or siblings increased the risk of VF or
SCD with an OR of 2.7 for VF13 and 1.6 for SCD.36 These
ﬁndings, in combination with the results of the present study
(OR 1.6 for VF), lend support for the hypothesis that a portion
of the familial aggregation of VF and SCD37 is distinct from
that for atherosclerosis. Factors that directly predispose to
fatal arrhythmia may be responsible, providing a rationale for
further research on genetic determinants of VF in the STEMI
population.
Whether age and sex are associated with VF is not clear. In
our data, age was paradoxically associated with VF, with
higher risks among those aged <60 years. This association
could be due, at least in part, to higher resuscitation and
survival rates for out-of-hospital VF in younger persons;
however, a recent study also showed age of <60 years to be
signiﬁcantly associated with in-hospital VF in the setting of
MI.33 Given the high lethality of VF, patients with a genetic
and/or physiologic predisposition to VF in the setting of MI
may be less likely to survive to an older age. Men also tended
to have a higher risk of VF in the setting of STEMI in our
population, consistent with the higher incidence of SCD
among men in several studies;3 however, after controlling for
alcohol intake, the association became nonsigniﬁcant.
Apart from age, other standard cardiovascular risk factors
were not associated with VF in our population of STEMI
patients after multivariable adjustment. These results are
largely in agreement with the AGNES study, which also
examined risk factors for VF before PPCI, except the latter
study found an inverse association between hypercholester-
olemia and VF among 275 cases and 325 controls with an OR
of 0.64 (P=0.027).13 We found a positive association between
statin therapy and VF in the adjusted regression analysis that
is difﬁcult to interpret in this observational study, given the
potential for confounding by indication. All patients on statins
before STEMI with VF were diagnosed with hypercholesterol-
emia, and treatment with a statin may be a proxy for higher
cholesterol levels and/or higher cardiovascular risk proﬁle.
Preinfarction angina was inversely associated with VF (OR
0.46) in our study and in a small cohort of 72 consecutive out-
of-hospital VF patients with MI (OR 0.40) and in a meta-
analysis8,15 but not in the AGNES study.13 Preinfarction angina
may act as a clinical surrogate for ischemic preconditioning,
which recently has been demonstrated to reduce infarct size in
STEMI patients.38 Furthermore, animal studies have shown
that preconditioning protects against VF during acute coronary
occlusion.39,40 A completely occluded artery is also associated
with a higher risk of VF in STEMI patients both prior to PPCI in
the present study and during and after catheterization in
another.10 Our study also presents supporting data to suggest
that an anterior location of the MI and/or a left anterior
descending culprit artery occlusion may also elevate VF
risk.13,14,33 Although anterior MI location may be a proxy for
infarct size, which is difﬁcult to accurately measure in the
setting of resuscitated VF arrest, studies controlling for infarct
size still found an anterior location to be associated with VF.13
Strengths and Limitations
Patients who died outside of hospitals are not included in the
present study; therefore, our resultsmay not be generalizable to
STEMI patients who do not survive to reach the hospital and
who do not undergo angiography. Even though we had
permission to include patients before informed consent, it
was not possible to include all patients (Figures 1 and 2). The
ratio of cases and controls enrolled in the study differed across
the centers, and different enrollment patterns and patient
populations across centers could have inﬂuenced our analysis;
however, the baseline characteristics of case and control
patients across centerswere similar with respect to all variables
besides the proportion with previous hypercholesterolemia in
the case group (P=0.032), and control for center did not affect
our results. There is also the potential for recall bias, which is a
limitation in any case–control study in which the exposure is
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ascertained after the event. Baseline characteristics and
especially symptoms prior to STEMI with VF could have been
underreported in the case group because of retrograde amnesia
or overrepresented due to recall bias; therefore, all potential
sources were used to retrieve complete data through the
national electronic health records and contacting of the next
of kin and the patients after discharge. Recall bias with
respect to family history could have been present in both
groups; nevertheless, we were able to replicate the associ-
ation of family history of sudden death to VF shown in
previous studies.13,36 With respect to our ﬁndings on alcohol
intake, we did not collect information on drinking pattern or
recent withdrawal from alcohol and thus were unable to
analyze how these factors might inﬂuence VF risk. We also
did not ask about diet (eg, coffee intake) or illegal drug use,
such as cocaine, that could increase the risk of VF. Finally,
our results in this population with white, European ancestry
may not be generalizable to other populations.
Conclusion
Several easily assessed risk factors were found to be
associated with a subsequent higher risk of VF in STEMI.
Novel risk factor with potential clinical implications in this
population include alcohol intake of >7 units per week. This
study also identiﬁed and conﬁrmed younger age, prior history
of AF, family history of sudden death, and absence of
preinfarction angina as risk factors associated with VF.
Because AF patients and those with a family history of sudden
death are at higher risk of sudden death during an acute MI
due to VF, targeting these patients for aggressive primary
prevention of MI may be warranted. Our data also raise the
possibility that alcohol intake might affect the risk of VF in the
setting of STEMI. Furthermore, because younger patients and
those without preceding angina appear to be at higher risk for
VF in the setting of STEMI, these data could be useful when
counseling younger, apparently healthy persons regarding the
importance of CAD and lifestyle risk-factor modiﬁcation to
prevent MI and sudden death.
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